Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

44 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Ductal Adenocarcinoma trial results

Active, not recruiting

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT06608927

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Alamitos, California, United States
View all 111 locations
View Trial Details
Active, not recruiting

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT06168812

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05642962

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

NCT04666740

Conditions
Homologous Recombination Deficiency (HRD), Metastatic Pancreatic Ductal Adenocarcinoma
Locations
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison, New York, United States
View Trial Details
Active, not recruiting

Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients

NCT04888312

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Cliniques Universitaires St-Luc Brussels, Belgium
  • Hospital Erasme Brussels, Belgium
  • UZA Antwerp Edegem, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
View all 14 locations
View Trial Details

Related conditions